SECURITIES AND EXCHANGE COMMISSION

                     WASHINGTON, D.C.  20549

        __________________________________________________

                            FORM 10-Q

            Quarterly Report Under Section 13 or 15(d)
                              of the
                      Securities Act of 1934

               FOR QUARTER ENDED SEPTEMBER 30, 1996
                  Commission File Number 0-12248

                        DAXOR CORPORATION

             (Exact Name as Specified in its Charter)


               New York                       13-2682108
     (State or Other Jurisdiction of       (I.R.S. Employer
     Incorporation or Organization)        Identification No.)

                          350 Fifth Ave
                            Suite 7120
                     New York, New York 10118

(Address of Principal Executive Offices & Zip Code)

Registrant's Telephone Number:     (212) 244-0555
    (Including Area Code)

     Indicate by check mark whether the registrant (1) has filed all
reports required by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter
period that the registrant was required to file such reports), and
(2) has been subject to such filing requirements for the past 90
days.

               Yes  (X)                No      

     Indicate the number of shares outstanding of each of the
issuer's classes of common stock, as of the latest practicable date. 


       CLASS                     OUTSTANDING AT SEPTEMBER 30, 1996 
   COMMON STOCK                              4,722,709
PAR VALUE: $.O1 per share 

<PAGE>

                            SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned thereunto duly authorized.



                                        DAXOR CORPORATION
                                           (Registrant)




DATE: November 15, 1996                  /S/JOSEPH FELDSCHUH       
 
                                          JOSEPH FELDSCHUH,M.D.
                                          President       
 

DATE: November 15, 1996                   /S/ROBERT ROSENTHAL     
  
                                          ROBERT ROSENTHAL,M.D. 
                                          Vice President


DATE: November 15, 1996                   /S/OCTAVIA ATANASIU      
 
                                          OCTAVIA ATANASIU
                                          Treasurer


DATE: November 15, 1996                   /S/VIRGINIA FITZPATRICK  

                                          VIRGINIA FITZPATRICK   
                                          Corporate Secretary


<PAGE>
PART I.   FINANCIAL INFORMATION


ITEM 1.   FINANCIAL STATEMENTS                              PAGE

          Consolidated Balance Sheets as at
            September 30, 1996 and December 31,1995          2


          Consolidated Statements of Operations for the
            Three and Nine Months ended September 30, 1996     
            and 1995                                         3


          Consolidated Statements of Cash Flows for the
            Nine Months ended September 30, 1996 and 1995    4


          Notes to Financial Statements                      5

                        
          Exhibit - 27 Supplementary Exhibit As required 
            by the Securities and Exchange Commission        Exhibit 1